Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 18 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 18 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Therapist-Guided Home Stroke Rehab System in Works

Stroke rehab objects

A university lab is designing a system that allows for people with stroke to perform rehabilitation at home, while still guided remotely by a therapist. . . . → Read More: Therapist-Guided Home Stroke Rehab System in Works

Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Bumble bee and flower

A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Natural-Killer Cell Cancer Therapy Biotech Launches

Natural killer cell

A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches

Infographic – Vaccines Boost Biotech Shares

Biotech share prices chart

News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic. . . . → Read More: Infographic – Vaccines Boost Biotech Shares

Cancer Immune System Therapy Start-Up Raises $53M

T-cells illustration

A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M

$500K Challenge Seeks A.I. Covid-19 Reopening Models

Synthetic biology

A new challenge from XPrize seeks evidence-based models using artificial intelligence to help governments reopen their economies during the pandemic. . . . → Read More: $500K Challenge Seeks A.I. Covid-19 Reopening Models

Gene-Editing Enzyme Start-Up Gains $65M

Crispr graphic

A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round. . . . → Read More: Gene-Editing Enzyme Start-Up Gains $65M

Coronavirus Antibody Maker Raises $80M in New Funds

Bat hanging upside down

A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds. . . . → Read More: Coronavirus Antibody Maker Raises $80M in New Funds

Salk, Energy Utility Partner on Carbon Capture Plants

Sorghum field

A California energy utility and Salk Institute are collaborating on engineering new plant varieties that capture and store more carbon dioxide in the ground. . . . → Read More: Salk, Energy Utility Partner on Carbon Capture Plants